These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6651612)

  • 21. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.
    Blankenhorn DH; Alaupovic P; Wickham E; Chin HP; Azen SP
    Circulation; 1990 Feb; 81(2):470-6. PubMed ID: 2404631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO
    Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lovastatin or niacin combined with colestipol and regression of coronary atherosclerosis.
    Brown BG
    Eur Heart J; 1992 Jul; 13 Suppl B():17-20. PubMed ID: 1644095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment.
    Kuo PT; Kostis JB; Moreyra AE; Hayes JA
    Chest; 1981 Mar; 79(3):286-91. PubMed ID: 7471860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
    Illingworth DR
    Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H
    Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid and lipoprotein profiles in children with familial hypercholesterolaemia: effects of therapy.
    Hennermann JB; Herwig J; März W; Asskali F; Böhles HJ
    Eur J Pediatr; 1998 Nov; 157(11):912-8. PubMed ID: 9835436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in very low and low density lipoproteins with dietary fat modification.
    Weisweiler P; Drosner M; Janetschek P; Schwandt P
    Atherosclerosis; 1983 Dec; 49(3):325-32. PubMed ID: 6661270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
    Crouse JR; Grundy SM
    Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia.
    Gavish D; Oschry Y; Fainaru M; Eisenberg S
    Eur J Clin Invest; 1986 Feb; 16(1):61-8. PubMed ID: 3084275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination drug therapy for familial combined hyperlipidemia.
    East C; Bilheimer DW; Grundy SM
    Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of etiroxate on low density and high density lipoproteins in hypercholesterolemic patients.
    Weisweiler P; Schwandt P
    Atherosclerosis; 1981 Apr; 39(1):45-9. PubMed ID: 7247989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a rapeseed oil substituting diet on serum lipids and lipoproteins in children and adolescents with familial hypercholesterolemia.
    Gulesserian T; Widhalm K
    J Am Coll Nutr; 2002 Apr; 21(2):103-8. PubMed ID: 11999536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine.
    Hasler-Rapacz J; Kempen HJ; Princen HM; Kudchodkar BJ; Lacko A; Rapacz J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):137-43. PubMed ID: 8548414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The selective lipid-lowering effect of vegetarianism on low density lipoproteins in a cross-over experiment.
    Cooper RS; Goldberg RB; Trevisan M; Tsong Y; Liu K; Stamler J; Rubenstein A; Scanu AM
    Atherosclerosis; 1982 Sep; 44(3):293-305. PubMed ID: 7150394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
    Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia.
    King JM; Crouse JR; Terry JG; Morgan TM; Spray BJ; Miller NE
    Am J Med; 1994 Oct; 97(4):323-31. PubMed ID: 7942933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
    Hoogwerf BJ; Peters JR; Frantz ID; Hunninghake DB
    Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled studies of the efficacy and safety of combined probucol-colestipol therapy.
    Dujovne CA; Krehbiel P; Chernoff SB
    Am J Cardiol; 1986 Jun; 57(16):36H-42H. PubMed ID: 3524176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.